Generalized Expectancies for Negative Mood Regulation and Major Depressive Disorder: The Role of Previous Depressive Episodes and Comorbid Mental DisordersPfeiffer N.a · Kaemmerer A.a · Mearns J.c · Catanzaro S.J.d · Backenstrass M.b
aDepartment of Psychology, University of Heidelberg, and bClinic for General Adult Psychiatry, University Hospital of Heidelberg, Heidelberg, Germany; cDepartment of Psychology, California State University, Fullerton, Calif., and dDepartment of Psychology, Illinois State University, Normal, Ill., USA
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
Article / Publication Details
Background: Generalized expectancies for negative mood regulation (NMR) have important consequences for the ability to regulate negative mood. This study tests two resulting hypotheses. NMR expectancies should correlate with the number of previous depressive episodes. Furthermore, there should be a correlation between NMR expectancies and the number of DSM-IV axis I disorders comorbid to depression. In order to test these hypotheses with an efficient instrument, this article presents the NMR-SF as a short form of the NMR Scale. Methods: During inpatient treatment, a sample of 40 depressed patients was interviewed by a clinical psychologist with the Structural Clinical Interview for DSM-IV to assess the number of previous depressive episodes as well as the number of axis I comorbidities. Patients completed the NMR-SF to measure NMR expectancies. Additionally, a nonclinical sample of 560 participants completed the NMR-SF to test its reliability and validity. Results: The findings indicate that the NMR-SF is reliable and valid. In the clinical sample, NMR expectancies did not correlate significantly with the number of previous depressive episodes. There was a significant correlation between NMR expectancies and the number of comorbid mental disorders. Conclusion: Previous depressive episodes do not seem to result in lower NMR expectancies. The findings are in line with the hypothesis that NMR expectancies are involved in the etiology of mental disorders comorbid to depression.
© 2011 S. Karger AG, Basel
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 4, rev (DSM-IV-TR). Washington D.C., American Psychiatric Association, 2000.
Kring AM, Sloan, DM: Emotion Regulation and Psychopathology: A Transdiagnostic Approach to Etiology and Treatment. New York, Guilford Press, 2010.
Gross JJ: Handbook of Emotion Regulation. New York, Guilford Press, 2007.
- Backenstrass M, Joest K, Gehrig N, Pfeiffer N, Mearns J, Catanzaro SJ: The German version of the Generalized Expectancies for Negative Mood Regulation Scale: a construct validity study. Eur J Psychol Assess 2010;26:28–38.
- Gilboa-Schechtman E, Avnon L, Zubery E, Jeczmien P: Emotional processing in eating disorders: specific impairment or general distress related deficiency? Depress Anxiety 2006;62:331–339.
- Thorberg FA, Lyvers M: Negative mood regulation (NMR) expectancies, mood, and affect intensity among clients substance disorder treatment facilities. Addict Behav 2006;31:811–820.
- Cloitre M, Miranda R, Stovall-McClough KC, Han H: Beyond PTSD: emotion regulation and interpersonal problems as predictors of functional impairment in survivors of childhood abuse. Behavior Therapy 2005;36:119–124.
- Cloitre M, Koenen KC, Cohen LC, Han H: Skills training in affective and interpersonal regulation followed by exposure: a phase-based treatment for PTSD related to childhood abuse. J Consult Clin Psychol 2002;70:1067–1074.
- Cloitre M, Stovall-McClough KC, Miranda R, Chemtob CM: therapeutic alliance, negative mood regulation, and treatment outcome in child abuse-related posttraumatic stress disorder. J Consult Clin Psychol 2004;72:411–416.
- Backenstrass M, Schwarz T, Fiedler P, Joest K, Reck C, Mundt C, Kronmueller KT: Negative mood regulation expectancies, self-efficacy beliefs, and locus of control orientation: moderators or mediators of change in the treatment of depression? Psychother Res 2006;16:250–258.
- Catanzaro SJ, Mearns J: Measuring generalized expectancies for negative mood regulation: initial scale development and implications. J Pers Assess 1990;54:546–563.
Kirsch I: Response expectancies: an introduction; in Kirsch I (ed): How Expectancies Shape Experience. Washington D.C., American Psychological Association, 1999, pp 3–13.
Rotter JB: The Development and Application of Social Learning Theory. New York, Praeger, 1982.
Catanzaro SJ, Mearns J: Mood-related expectancy, emotional experience, and coping behavior; in Kirsch I (ed): Expectancy, Experience and Behavior. Washington D.C., American Psychological Association, 1999, pp 67–91.
- Zuroff DC, Blatt SJ, Krupnick JL, Sotsky SM: Enhanced adaptive capacities after brief treatment for depression. Psychother Res 2003;13:99–115.
Abramson LY, Alloy LB, Metalsky GI: Hopelessness depression: A theory-based subtype of depression. Psychol Rev 96;358–372.
- Backenstrass M, Pfeiffer N, Schwarz T, Catanzaro SJ, Mearns J: Reliabilität und Validität der deutschsprachigen Version der Generalized Expectancies for Negative Mood Regulation (NMR) Scale. Diagnostica 2008;54:43–51.
- Catanzaro SJ, Wasch HW, Kirsch I, Mearns J: Coping-related expectancies and dispositions as prospective predictors of coping responses and symptoms. J Pers 2000;68:757–788.
- Davis RN, Andresen EN, Trosko M, Massman PJ, Lovejoy MC: Negative mood regulation (NMR) expectancies: a test of incremental validity. Pers Individ Diff 2005;39:263–270.
- Kassel JD, Bornovalova M, Mehta N: Generalized expectancies for negative mood regulation predict change in anxiety and depression among college students. Behav Res Ther 2007;45:939–950.
- Keller MB, Boland RJ: Implications of failing to achieve successful long-term maintenance treatment of recurrent unipolar major depression. Biol Psychiatry 1998;44:348–360.
- Kronmüller KT, Backenstrass M, Victor D, Postelnicu I, Schenkenbach C, Joest K, Fiedler P, Mundt C: Expressed emotion, perceived criticism and 10-year outcome of depression. Psychiatry Res 2008;159:50–55.
- Solomon DA, Keller MB, Leon AC, Mueller TI, Lavori PW, Shea MT, Coryell W, Warshaw M, Turvey C, Maser JD, Endicott J: Multiple recurrences of major depressive disorder. Am J Psychiatry 2000;157:229–233.
- Kessing LV, Andersen PK: The effect of episodes on recurrence in affective disorder: a case register study. J Affect Disord 1999;53:225–231.
- MacKinnon DP, Fairchild AJ, Fritz MS: Mediation analysis. Annu Rev Psychol 2007;58:593–614.
- Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, Rush AJ, Walters EE, Wang PS: The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 2003;289:3095–3105.
- Roy-Byrne PP, Stang P, Wittchen HU, Ustun B, Walters EE, Kessler RC: Lifetime panic-depression comorbidity in the National Comorbidity Survey. Association with symptoms, impairment, course and help-seeking. Br J Psychiatry 2000;176:229–235.
- Lewinsohn PM, Rohde P, Seeley JR: Adolescent psychopathology: III. The clinical consequences of comorbidity. J Am Acad Child Adolesc Psychiatry 1995;34:510–519.
Schoevers RA, Deeg DJ, van Tilburg W, Beekman AT: Depression and generalized anxiety disorder: co-occurrence and longitudinal patterns in elderly patients. Am J Geriatr Psychiatry 2005;13:3–39.
- Melartin TK, Rytsälä HJ, Leskelä US, Lestelä-Mielonen PS, Sokero TP, Isometsä ET: Severity and comorbidity predict episode duration and recurrence of DSM-IV major depressive disorder. J Clin Psychiatry 2004;65:810–819.
- Coryell W, Endicott J, Winokur G: Anxiety syndromes as epiphenomena of primary major depression: outcome and familial psychopathology. Am J Psychiatry 1992;149:100–107.
- Smith GT, McCarthy DM, Anderson KG: On the sins of short-form development. Psychol Assess 2000;12:102–111.
Wittchen HU, Zaudig M, Fydrich T: Strukturiertes Klinisches Interview für DSM-IV, Achse I und II. Göttingen, Hogrefe, 1997.
Hautzinger M, Bailer M, Worall H, Keller F: Beck-Depressions-Inventar, Testhandbuch, ed 2. Bern, Huber, 1995.
- Richter P, Werner J, Heerlein A, Kraus A, Sauer H: On the validity of the Beck Depression Inventory: a review. Psychopathology 1998;31:160–168.
- Radloff LS: The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1977;1:385–401.
Hautzinger M, Bailer M: Allgemeine Depressions Skala. Göttingen, Beltz, 1993.
- O’Connor BP: SPSS and SAS programs for addressing interdependence and basic levels-of-analysis issues in psychological data. Behav Res Methods Instrum Comput 2004;36:17–28.
- Klein DN, Shankman SA, Rose S: Ten-year prospective follow-up study of the naturalistic course of dysthymic disorder and double depression. Am J Psychiatry 2006;163:872–880,
- Leon AC, Solomon DA, Mueller TI, Turvey CL, Endicott J, Keller MB: The Range of Impaired Functioning Tool (LIFE-RIFT): a brief measure of functional impairment. Psychol Med 1999;29:869–878.
- Judd LL, Akiskal HS, Zeller PJ, Paulus M, Leon AC, Maser JD, Endicott J, Coryell W, Kunovac JL, Mueller TI, Rice JP, Keller MB: Psychosocial disability during the long-term course of unipolar major depressive disorder. Arch Gen Psychiatry 2000;57:375–380.
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.